Category: Insights

The Importance of Pharmaceutical Competitor Analysis

The US pharmaceutical industry is heavily competitive, with nine out of the top ten pharmaceutical companies based in the US. In recent years though, the market has become even more competitive…
The post The Importance of Pharmaceutical Competito…


Celgene vs. Dr. Reddy’s Revlimid patent infringement case depends on polymorph stability; lack thereof may favor Celgene position – experts

This article was originally published on November 30th 2017 by Hamish McDougall and Alaric DeArment of BioPharm Insight, part of GlobalData. Polymorph differences support noninfringement argument Trace solvate amount could destabalise…
The post C…


Making Medicines Affordable: A National Imperative

Consumer access to effective and affordable medicines is an imperative for public health, social equity, and economic development, but this need is not being served adequately by the biopharmaceutical sector,…
The post Making Medicines Affordable…


Unapproved Drugs: Opportunities for Rapid Approval and Market Exclusivity

Contrary to popular belief, there are many unapproved drugs which are actively being used. Many physicians may not even realize that that the drugs they are prescribing have not been…
The post Unapproved Drugs: Opportunities for Rapid Approval an…


Strategies for Pharmaceutical Companies to Boost Their Exports

Changes in the pharmaceutical sales model have forced leaders to invest in new selling strategies in recent years. However most of these New Commercial Models (NCMs) have not produced enough…
The post Strategies for Pharmaceutical Companies to Bo…


Patent Protection Strategies

This article was originally published by Himanshu Gupta, Suresh Kumar, Saroj Kumar Roy, and R. S. Gaud at J Pharm Bioallied Sci. 2010 Jan-Mar; 2(1): 2–7. Abstract It is widely recognized…
The post Patent Protection Strategies appeared first on Dr…


Factors that influence the development of generic drugs in the US

The trillion dollar pharmaceutical sector has been dominated for long by a few giant firms that manufacture and supply the major branded prescription drugs. However, recent trends point to the…
The post Factors that influence the development of g…


Re-Thinking Management Strategies for Specialty Drug Cost Containment

A 2016 report by the Kaiser Family Foundation reported that approximately one-quarter of the people in the United States have difficulty affording their medications. For low-income individuals, the cost of…
The post Re-Thinking Management Strateg…


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: